Cargando…

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

OBJECTIVES: Increased renal sinus fat (RSF) is associated with hypertension and chronic kidney disease, but underlying mechanisms are incompletely understood. We evaluated relations between RSF and gold-standard measures of renal hemodynamics in type 2 diabetes (T2D) patients. METHODS: Fifty-one T2D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spit, Karlinde A., Muskiet, Marcel H. A., Tonneijck, Lennart, Smits, Mark M., Kramer, Mark H. H., Joles, Jaap A., de Boer, Anneloes, van Raalte, Daniel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021744/ https://www.ncbi.nlm.nih.gov/pubmed/31471702 http://dx.doi.org/10.1007/s10334-019-00773-z

Ejemplares similares

Plasma uric acid and renal haemodynamics in type 2 diabetes patients
por: Suijk, Danii LS, et al.
Publicado: (2019)

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
por: Tonneijck, Lennart, et al.
Publicado: (2016)

Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial
por: Muskiet, Marcel H. A., et al.
Publicado: (2021)

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study
por: Bouman, Emma J., et al.
Publicado: (2021)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
por: Tonneijck, Lennart, et al.
Publicado: (2019)

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
por: Smits, Mark M, et al.
Publicado: (2015)

Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8‐week, randomized, controlled, double‐blind trial
por: Kraaijenhof, Jordan, et al.
Publicado: (2020)

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
por: Smits, Mark M., et al.
Publicado: (2016)

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
por: Smits, Mark M., et al.
Publicado: (2016)

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
por: Sivalingam, Suvanjaa, et al.
Publicado: (2021)

Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes
por: Smits, M. M., et al.
Publicado: (2017)

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
por: Scholtes, Rosalie A., et al.
Publicado: (2021)

Decreased native renal T(1) up to one week after gadobutrol administration in healthy volunteers
por: de Boer, Anneloes, et al.
Publicado: (2019)

Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors
por: Scholtes, Rosalie A., et al.
Publicado: (2020)

Multiparametric Renal MRI: An Intrasubject Test–Retest Repeatability Study
por: de Boer, Anneloes, et al.
Publicado: (2020)

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet
por: Scholtes, Rosalie A., et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio Predicts Pathological Renal Sinus Fat Invasion in Renal Cell Carcinomas of ≤7 cm with Presumed Renal Sinus Fat Invasion
por: Kim, Jongchan, et al.
Publicado: (2019)

Left Ventricular Mass: Correlation with Fatness, Hemodynamics and Renal Morphology
por: Wykrętowicz, Mariusz, et al.
Publicado: (2014)

Associations of renal sinus fat with blood pressure and ectopic fat in a diverse cohort of adults
por: Couch, Catharine A., et al.
Publicado: (2022)

The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A
por: Wagner, R., et al.
Publicado: (2017)

T-cells contribute to hypertension but not to renal injury in mice with subtotal nephrectomy
por: Oosterhuis, Nynke R., et al.
Publicado: (2017)

Nitric Oxide Synthase Inhibition Induces Renal Medullary Hypoxia in Conscious Rats
por: Emans, Tonja W., et al.
Publicado: (2018)

Development and reproducibility of a computed tomography-based measurement of renal sinus fat
por: Foster, Meredith C, et al.
Publicado: (2011)

The Effects of Renal Denervation on Renal Hemodynamics and Renal Vasculature in a Porcine Model
por: Verloop, Willemien L., et al.
Publicado: (2015)

Consequences of perinatal treatment with l-arginine and antioxidants for the renal transcriptome in spontaneously hypertensive rats
por: Wesseling, Sebastiaan, et al.
Publicado: (2009)

Renal Sinus Fat Invasion and Tumoral Thrombosis of the Inferior Vena Cava-Renal Vein: Only Confined to Renal Cell Carcinoma
por: Acar, Turker, et al.
Publicado: (2014)

Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
por: Spit, Karlinde Amber, et al.
Publicado: (2022)

Protective role of female gender in programmed accelerated renal aging in the rat
por: Pijacka, Wioletta, et al.
Publicado: (2015)

Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems
por: Scammahorn, Joshua J., et al.
Publicado: (2021)

Bilirubin, Renal Hemodynamics, and Blood Pressure
por: Stec, David E., et al.
Publicado: (2012)

Corrigendum: Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

The Difference in Prognosis between Renal Sinus Fat and Perinephric Fat Invasion for pT3a Renal Cell Carcinoma: A Meta-Analysis
por: Zhang, Zhiling, et al.
Publicado: (2016)

Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications
por: Ni, Dong, et al.
Publicado: (2017)

Renal and renal sinus fat volumes as quantified by magnetic resonance imaging in subjects with prediabetes, diabetes, and normal glucose tolerance
por: Notohamiprodjo, Mike, et al.
Publicado: (2020)

Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial
por: Courand, Pierre‐Yves, et al.
Publicado: (2017)

Angiotensin II-induced hypertension in rats is only transiently accompanied by lower renal oxygenation
por: Emans, Tonja. W., et al.
Publicado: (2018)

Measurement of the Surface Area of the Renal Sinus Fat Using MDCT: Correlation with Presence and Severity of Essential Hypertension and Body Mass Index
por: Abdeldayem, Emad H., et al.
Publicado: (2022)

Elevated renal tissue oxygenation in premature fetal growth restricted neonates: An observational study
por: Terstappen, Fieke, et al.
Publicado: (2018)

Invasive maxillary sinus mass in a renal transplant patient*
por: Johnson, Mark D., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_7dfote4ah63d4uipp1reeaguk8